Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients - Part I: Young subjects

Neuropsychobiology

Volumn 60, Issue 1, 2009, Pages 44-48

  Spivak, Baruch ^a,b   Schechtman, Mila ^d   Blumensohn, Rachel ^a,b   Schönherz Pine, Yael ^a   Yoran Hegesh, Roni ^a,b   Deckmann, Michael ^c   Mayer, Rina ^c   Weizman, Abraham ^b,e   Shinitzky, Meir ^d  

^a NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c Neurogenic   (Israel)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

Autoantibodies; Blood test; Diagnosis; Platelets; Schizophrenia; Young subjects

Indexed keywords

AUTOANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITALIZATION; HUMAN; MALE; OPTICAL DENSITY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; THROMBOCYTE COUNT; VALIDATION PROCESS;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD PLATELETS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS; TIME FACTORS; YOUNG ADULT;

EID: 69549114230     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000235801     Document Type: Article

References (22)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
2. Freedman R: Schizophrenia. New Engl J Med 2003; 349: 1738-1749.
3. Rupp A, Keith SJ: The costs of schizophrenia: Assessing the burden. Psychiatr Clin North Am 1993; 16: 413-423.
4. Jones AL, Mowry BJ, Pender MP, Greer JM: Immune dysregulation and self-reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 2005; 83: 9-17.
5. Knight JG, Menkes DB, Highton J, Adams DD: Rationale for a trial of immunosuppressive therapy in acute schizophrenia. Mol Psychiatry 2007; 12: 424-431.
6. Strous RD, Shoenfeld Y: Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive model updated and revisited. J Autoimmun 2006; 27: 71-80.
7. Shinitzky M, Deckmann M, Kessler A, Sirota P, Rabbs A, Elizur A: Platelet autoantibodies in dementia and schizophrenia-possible implication for mental disorders. Ann NY Acad Sci 1991; 621: 205-217.
8. Kessler A, Shinitzky M: Platelets from schizophrenic patients bear autoimmune antibodies that inhibit dopamine uptake. Psychobiology 1993; 21: 299-306.
9. Deckmann M, Shinitzky M, Leykin I, Cheng D, Guy J, Sirota P, et al.: Humoral and cellular response against autologous platelets. Ital J Psych Behav Sci 1996; 6: 29-34.
10. Schwarz MJ, Ackenheil M, Riedel M, Muller N: Blood-cerebrospinal fluid barrier impairment as indicator for an immune process in schizophrenia. Neurosci Lett 1998; 253: 201-203.
11. Shinitzky M, Leykin I, Deckmann M: Autoimmunity against platelets in schizophrenia; in The Decade of Autoimmunity. Amsterdam, Elsevier, 1999, pp 277-284.
12. Deckmann M, Mamillapalli R, Schechtman L, Shinitzky M: A conformational epitope which detects autoantibodies from schizophrenic patients. Clinica Chemica Acta 2002; 322: 91-98.
13. First MB, Spitzer RL, Gibbon M, et al.: Structured Clinical Interview for Axis I DSM-IV Disorders, Patient Version (SCID-I/P), Version 2. New York, New York State Psychiatric Institute Biometrics Research Department, 1995.
14. Kay S, Fiszbein A, Opler LA: The Positive and Negative Syndrome Scale for schizophrenia. Schizophr Bull 1987; 13: 261-276.
15. Schwarz M, Spector L, Gortler M, et al.: Serum anti-Glc( α 1,4)Glc( α ) antibodies as a biomarker for relapsing-remitting multiple sclerosis. J Neurol Sci 2006; 244: 59-68.
16. Spivak B, Schechtman M, Blumensohn R, Schönherz-Pine Y, Yoran-Hegesh R, Deckmann M, Mayer R, Weizman A, Shinitzky M: Blind verification of elevated platelet autoantibodies in serum of schizophrenic patients. Part II. Adult subjects. Neuropsychobiology 2009;60: 49-54.
17. Aster AH, Bougie D: Drug-induced immune thrombocytopenia. New Engl J Med 2007; 357: 580-587.
18. George JN, Raskob GE, Shah SR, Rizvi MA, Hamilton SA, Osborne S, Vondracek T: Drug-induced thrombocytopenia: A systematic review of published case reports. Ann Intern Med 1998; 129: 886-890.
19. Levine J, Susnovski M, Handzel Z, Leykin I, Shinitzky M: Treatment of schizophrenia with an immunosuppressant. Lancet 1994; 344: 59-60.
20. Canoso RT, deOliviera RM, Nixon RA: Neuroleptic- associated autoantibodies: A prevalence study. Biol Psychiatry 1990; 27: 863-870.
21. Lillicap DP, Pinto M, Benford K, Ford PM, Ford S: Heterogenicity of laboratory test results for antiphospholipid antibodies in patients treated with chloropromazine and other phenothiazines. Am J Clin Pathol 1990; 93: 771-775.
22. Schwartz M, Silver H: Lymphocytes, autoantibodies and psychosis - coincidence versus etiological factors: An update. Isr J Psychiatry Relat Sci 2000; 37: 32-36.